Piramal Pharma share price
You have to be logged in to add this to Watchlist.- ₹164.10(0.40%)February 11, 2026 14:57:49 PM IST
- NSE
- BSE
- Vol : 1.17 M (NSE + BSE)Last 20 day avg : 3.84 M
Piramal Pharma is trading 0.40% upper at Rs 164.10 as compared to its last closing price. Piramal Pharma has been trading in the price range of 164.60 & 162.15. Piramal Pharma has given -5.10% in this year & 1.36% in the last 5 days. There are 9 analysts who have initiated coverage on Piramal Pharma. There are 5 analysts who have given it a strong buy rating & 4 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of -136.19 Crores in its last quarter.Listed peers of Piramal Pharma include Divi's Laboratories (2.39%), Sun Pharmaceutical Industries (0.14%), Dr Reddy's Laboratories (1.22%).The Mutual Fund holding in Piramal Pharma was at 14.03% in 31 Dec 2025. The MF holding has increased from the last quarter. The FII holding in Piramal Pharma was at 29.66% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Feb 11, 2026, 09:27 AM UTC
- BetaHigh volatility1.54Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.60The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.09Annual dividends as a percentage of the stock price.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Neutral | 6,320.00 | 2.39 | 1,68,258.62 | 78.61 | 11.52 | 0.46 | 0.01 |
| Sun Pharmaceutical Industries | Bullish | 1,710.00 | 0.14 | 4,10,276.61 | 36.24 | 5.77 | 0.92 | 0.50 |
| Dr Reddy's Laboratories | Bullish | 1,271.00 | 1.22 | 1,05,954.21 | 18.63 | 3.14 | 0.63 | 2.34 |
| Cipla | Moderately Bearish | 1,348.85 | 0.50 | 1,08,956.30 | 22.95 | 3.87 | 0.87 | 0.81 |
| Torrent Pharmaceuticals | Bullish | 4,055.00 | -0.60 | 1,37,422.76 | 67.32 | 17.1 | 0.83 | 17.62 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-01-28 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-07-28 | Quarterly Results |
| 2025-05-14 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE0DK501011
- BSE Code543635
- NSE CodePPLPHARMA
Piramal Pharma is trading at 164.10 as on Wed Feb 11 2026 09:27:49. This is 0.40% upper as compared to its previous closing price of 163.45.
The market capitalization of Piramal Pharma is 21799.62 Cr as on Wed Feb 11 2026 09:27:49.
The average broker rating on Piramal Pharma is Strong Buy. The breakup of analyst rating is given below -
- 5 analysts have given a strong buy rating
- 4 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Piramal Pharma is 241.00 whereas the 52 wk low is 148.30
Piramal Pharma can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 23.33
- Dividend Yield: 0.09%
- D/E ratio: -
Piramal Pharma reported a net profit of 91.13 Cr in 2025.
The Mutual Fund Shareholding was 14.03% at the end of 31 Dec 2025.